Takeda Pharmaceutical Company Limited NYQ · TAK
Price alert —
Sign in to get a one-time email the moment TAK crosses your price. Free accounts included.
Sign in / create a free accountTakeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.
TAK last traded at $16.87, down 2.1% on the day; that's in the middle part of its 52-week range ($14.84–$18.90). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.
The next scheduled earnings report (2026-07-30) is the biggest known catalyst on the calendar, and after a strong run, watch whether the price can hold its gains on quieter days.
A quick snapshot built from the data on this page — not investment advice. Always do your own research.
Price is stretched well above its normal range — a standard stretch that often pulls back toward normal.
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
- · KC2 upper stretch — standard mean-reversion tier
- · RSI hook from overbought (58)
- · Stochastic bear cross in overbought
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
TAK is a $53.9 billion company, it moves more calmly than the market (beta 0.1).
Options idea
See more →Earnings
See more →- Last reported
- 2023-07-27
- EPS (act / est)
- 28.76 / 18.62
- Surprise
- +54.4%
- Next report
- 2026-07-30
About
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti,…